RXRX Recursion Pharmaceuticals
Price Chart
Executive Summary
Recursion Pharmaceuticals granted inducement RSU awards covering ~2.99 million shares to 33 new employees under its 2024 Inducement Equity Incentive Plan, as a material inducement to their employment. The awards vest over four years with a one-year cliff. This is a routine equity grant for new hires and does not reflect any change in business operations or financial performance.
Actionable Insight
Routine inducement grants for new hires — no material impact on stock. Monitor for any future insider selling patterns or changes in employee retention, but this filing alone does not warrant trading action.
Key Facts
- Inducement RSU awards covering 2,991,840 shares granted to 33 new employees.
- Awards vest 1/4th on first quarterly vesting date after one-year anniversary, then 1/16th quarterly thereafter.
- Grants made under the 2024 Inducement Equity Incentive Plan per Nasdaq Listing Rule 5635(c)(4).
- No financial terms or performance metrics disclosed; standard new-hire equity compensation.
Financial Impact
~2.99 million shares granted, representing approximately 0.9% of outstanding shares (based on ~330M shares outstanding per market cap of $1.8B at ~$5.45/share). No cash consideration.
Risk Factors
- Potential dilution of ~0.9% over vesting schedule, but immaterial in near term.
- No performance conditions — awards are time-based, so retention risk if stock declines.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3303818 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
2d ago
|
Institutional Cluster
| $3.10 awaiting T+5 | awaiting T+5 | — | $3.15 (+1.61%) |
|
Jun 5, 2026
7d ago
|
Insider Cluster
| $3.32 awaiting T+5 | awaiting T+5 | — | $3.15 (−4.98%) |
|
May 29, 2026
14d ago
|
Press Release
| $3.79 $3.32 | ▼ −12.53% | ▼ −9.78% | $3.15 (−16.89%) |
|
May 6, 2026
5w ago
|
Press Release
| $3.43 $3.15 | ▼ −8.16% | ▼ −9.29% | $3.15 (−8.16%) |
|
May 5, 2026
5w ago
|
Insider Cluster
| $3.37 $3.26 | ▼ −3.26% | ▼ −5.25% | $3.15 (−6.53%) |
|
Apr 7, 2026
9w ago
|
Insider Cluster
| $3.19 $3.54 | ▲ +10.97% | ▲ +5.64% | $3.15 (−1.25%) |
|
Mar 25, 2026
11w ago
|
Press Release
| $3.17 $3.06 | ▼ −3.47% | ▼ −3.23% | $3.15 (−0.63%) |
|
Mar 17, 2026
12w ago
|
Insider Cluster
| $3.42 $3.17 | ▼ −7.31% | ▼ −4.66% | $3.15 (−7.89%) |
|
Feb 25, 2026
15w ago
|
8-K
| $3.77 $3.64 | ▼ −3.45% | ▼ −2.35% | $3.15 (−16.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access